Literature DB >> 2753035

Conformational analysis of brominated pA2'-5'A2'-5'A analogs. An NMR and model-building study.

Y T van den Hoogen1, C M Hilgersom, D Brozda, K Lesiak, P F Torrence, C Altona.   

Abstract

NMR and model-building studies were carried out on pA2'-5'A2'-5'A and analogs in which one or more of the A residues were replaced by 8-bromoadenosine. Chemical shifts, coupling constants and NOE data were used to obtain structural information. The N/S equilibrium constant of the ribose rings as well as the phase angles and puckering amplitudes were determined from the experimental coupling constants with the aid of an improved version of the PSEUROT program. Chemical shifts in combination with NOE data were used to monitor base-base interactions and the orientation of the bases (syn or anti). The combined data suggest that different types of stacking interactions are present in the various compounds. Bromination of the first or second residue in the trimers results in a preference for N-type sugar and syn orientation of the base in these residues. When A(3) is brominated, an S-type sugar conformation together with a syn orientation of the base is favoured at the 2' terminus. Energy-minimized models of the different stacking interactions are presented which fit the present collection of data. The possible correlation between biological activity of these compounds and their conformation is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2753035     DOI: 10.1111/j.1432-1033.1989.tb14872.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  2 in total

1.  8-Methyladenosine-substituted analogues of 2-5A: synthesis and their biological activities.

Authors:  Y Kitade; Y Nakata; K Hirota; Y Maki; A Pabuccuoglu; P F Torrence
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

Review 2.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.